Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024;43(1):51-59.
doi: 10.3233/BD-230037.

Primary breast sarcomas: A 13 case-series study treated in university hospital in central Tunisia over a 25-year period

Fadoua Bouguerra  1 , Samia Kanoun Belajouza  1   2 , Emna Mziou  3 , Rym Zanzouri  1 , Hayfa Chahdoura  1 , Sabrine Tbessi  1   2 , Nadia Bouzid  1   2 , Sameh Tebra Mrad  1   2
Affiliations

Primary breast sarcomas: A 13 case-series study treated in university hospital in central Tunisia over a 25-year period

Fadoua Bouguerra et al. Breast Dis. 2024.

Abstract

Aim: To retrospectively study the therapeutic modalities of primary breast sarcomas in view of the data of a local Tunisian experience.

Methods: It is a monocentric, descriptive, retrospective study including 13 cases of primary breast sarcoma treated over a period of 25 years (1995-2020) in the oncological radiotherapy department of a university hospital in Sousse, Tunisia.

Results: In our study, 13 cases of non-metastatic breast sarcomas that has been identified, divided into ten cases of phyllodes sarcomas and three cases of non-phyllodes sarcomas.Surgically, all our patients had a mastectomy. Among them, seven underwent a lymph node procedure: five underwent axillary lymph node dissection, and two others had primary axillary lymph node biopsy. For the adjuvant treatment, all the patients included in our study received radiotherapy and seven received chemotherapy. Local recurrence occurred on the operative scar in one patient after completion of radiation therapy. Metastatic relapse was described in five patients. The time to onset of metastases varied between two months and five years. Nevertheless, a complete remission was noted in 6 patients with a follow-up varying from four years to 20 years. Two patients were lost to follow-up.

Conclusion: Breast sarcomas remain a very rare entity of aggressive tumors.The therapeutic approach is poorly codified. For this reason, the therapeutic decision should always be discussed in a multidisciplinary assessment.

Keywords: Sarcoma; breast; chemotherapy; radiotherapy; surgery.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Patient selection chart, Farhat Hached University Hospital, Sousse, 1995–2020.
Fig. 2.
Fig. 2.
Decision matrix for therapeutic management in primary breast sarcoma.
See this image and copyright information in PMC

References

    1. McGowan TS, Cummings BJ, O’Sullivan B, Catton CN, Miller N, Panzarella T, An analysis of 78 breast sarcoma patients without distant metastases at presentation, Int J Radiat Oncol *Biology*Physics, 46(2): 383–390, 2000. - PubMed
    1. Lim SZ, Selvarajan S, Thike AA, Nasir NDBMd, Tan BKT, Ong KW et al. , Breast sarcomas and malignant phyllodes tumours: comparison of clinicopathological features, treatment strategies, prognostic factors and outcomes, Breast Cancer Res Treat, 159(2): 229–244, 2016. - PubMed
    1. Sang NV, Duc NM, My TTT, Ly TT, Bang LV, Thong PM, A rare case report of breast sarcoma, Radiol Case Rep, 16(5): 1047–1050, 2021. - PMC - PubMed
    1. Toesca A, Spitaleri G, De Pas T, Botteri E, Gentilini O, Bottiglieri L et al. , Sarcoma of the breast: Outcome and reconstructive options, Clinical Breast Cancer, 12(6): 438–444, 2012. - PubMed
    1. Gronchi A, Miah AB, Dei Tos AP, Abecassis N, Bajpai J, Bauer S et al. , Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, 32(11): 1348–1365, 2021. - PubMed